KV Pharma To Shell Out $17M In FCA Settlement

By Christopher Norton · December 6, 2011, 6:42 PM EST

KV Pharmaceutical Co. agreed Tuesday to pay $17 million to resolve a former subsidiary's role in a long-running False Claims Act qui tam action alleging it wrongly reported to Medicaid and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

United States, ex rel v. Actavis Mid-Atlantic, et al

Case Number

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

August 29, 2002

Recent Articles By Christopher

March 06, 2012
Medtronic Had Burden In Device IP Suit, Fed Circ. Told
March 01, 2012
FDA Warns Of 2 Hazardous Chemicals Used In Drugs
March 01, 2012
Reglan Failure-To-Warn Suit Brought To Supreme Court
February 23, 2012
Ex-Unilab Atty Can Pursue FCA Claims, 2nd Circ. Hears
February 22, 2012
Insurer Aims To Duck Coverage Of Omeros FCA Suit
February 10, 2012
Judge Misread Patent Claims, Sanofi Tells Fed. Circ.
February 07, 2012
MGH Didn't Credit Researchers For Patents, Fed. Circ. Hears
February 06, 2012
Wake Forest Blasts Jury Interrogatories In Fed. Circ. IP Case
February 06, 2012
ProMedica Begs FTC Not To Make It Divest Ohio Hospital
February 03, 2012
NLRB Wrongly Awarded Nurses Back Pay, DC Circ. Hears